All stock lists
Staar Surgical Co (STAA)
United States · Delayed Price · Currency is USD
Ophthalmic Goods
23.13+0.52 (+2.28%)
Insider Score
––Not scored
STAA Insider Score
Insiders here have filed 14 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
STAA Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 93.53 M | 93.52 M | 57.80 M | 94.73 M | 44.32 M |
| Revenue Growth (YoY) | 111.04 % | — | — | — | — |
| Cost of Revenue | 23.81 M | 24.66 M | 14.06 M | 16.86 M | 11.52 M |
| Gross Profit | 69.73 M | 68.86 M | 43.74 M | 77.88 M | 32.80 M |
| SG&A Expense | 49.68 M | 41.53 M | 45.43 M | 44.22 M | 47.25 M |
| R&D Expense | 9.94 M | 9.93 M | 9.24 M | 9.21 M | 10.26 M |
| Operating Expenses | 59.63 M | 51.46 M | 54.68 M | 53.43 M | 57.52 M |
| Operating Income | 10.10 M | 17.40 M | -10.94 M | 24.44 M | -24.72 M |
| Pretax Income | 11.02 M | 8.22 M | -20.65 M | 18.79 M | -25.91 M |
| Tax Provision | 2.97 M | 3.01 M | -2.34 M | 9.91 M | -9.10 M |
| Net Income | 8.06 M | 5.21 M | -18.31 M | 8.88 M | -16.81 M |
| EPS (Basic) | 0.16 | 0.10 | -0.37 | 0.18 | -0.34 |
| EPS (Diluted) | 0.16 | 0.10 | -0.37 | 0.18 | -0.34 |
| Shares Outstanding | 50.32 M | 49.91 M | 49.76 M | 49.63 M | 49.52 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.